{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:50Z","timestamp":1786993730952,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,30]],"date-time":"2027-04-30T00:00:00Z","timestamp":1809043200000},"content-version":"am","delay-in-days":303,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","award":["ZIA BC 011513"],"award-info":[{"award-number":["ZIA BC 011513"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.lungcan.2026.109427","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:03:48Z","timestamp":1777305828000},"page":"109427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Epidermal growth factor receptor-targeted near-infrared photoimmunotherapy for malignant pleural mesothelioma"],"prefix":"10.1016","volume":"217","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1048-2824","authenticated-orcid":false,"given":"Miyu","family":"Kano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1339-4219","authenticated-orcid":false,"given":"Aki","family":"Furusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichiro","family":"Takao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0348-9422","authenticated-orcid":false,"given":"Motofumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1086-8826","authenticated-orcid":false,"given":"Peter L.","family":"Choyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1019-4112","authenticated-orcid":false,"given":"Hisataka","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lungcan.2026.109427_b0005","article-title":"Malignant pleural mesothelioma: an update","volume":"47","author":"Hajj","year":"2021","journal-title":"J. Bras. Pneumol."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109427_b0010","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/1759-7714.13814","article-title":"Prognostic factors for progression-free and overall survival in malignant pleural mesothelioma","volume":"12","author":"Guzm\u00e1n-Casta","year":"2021","journal-title":"Thorac Cancer"},{"issue":"11","key":"10.1016\/j.lungcan.2026.109427_b0015","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the international association for the study of lung cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109427_b0020","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1038\/bjc.2013.514","article-title":"The latency period of mesothelioma among a cohort of British asbestos workers (1978-2005)","volume":"109","author":"Frost","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"23","key":"10.1016\/j.lungcan.2026.109427_b0025","doi-asserted-by":"crossref","first-page":"15934","DOI":"10.3390\/ijerph192315934","article-title":"Disease Latency according to Asbestos Exposure Characteristics among Malignant Mesothelioma and Asbestos-Related Lung Cancer cases in South Korea","volume":"19","author":"Huh","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"13","key":"10.1016\/j.lungcan.2026.109427_b0030","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMra1912719","article-title":"Perspectives on the treatment of malignant pleural mesothelioma","volume":"385","author":"Janes","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2026.109427_b0035","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3390\/cancers17040694","article-title":"Recent advances in mesothelioma treatment: immunotherapy, advanced cell therapy, and other innovative therapeutic modalities","volume":"17","author":"Suraya","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.lungcan.2026.109427_b0040","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1021\/acs.accounts.9b00273","article-title":"Near-infrared photoimmunotherapy of cancer","volume":"52","author":"Kobayashi","year":"2019","journal-title":"Acc. Chem. Res."},{"issue":"12","key":"10.1016\/j.lungcan.2026.109427_b0045","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/nm.2554","article-title":"Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules","volume":"17","author":"Mitsunaga","year":"2011","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109427_b0050","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1021\/acscentsci.8b00565","article-title":"Photoinduced ligand release from a silicon phthalocyanine dye conjugated with monoclonal antibodies: a mechanism of cancer cell cytotoxicity after near-infrared photoimmunotherapy","volume":"4","author":"Sato","year":"2018","journal-title":"ACS Cent. Sci."},{"issue":"61","key":"10.1016\/j.lungcan.2026.109427_b0055","doi-asserted-by":"crossref","first-page":"104295","DOI":"10.18632\/oncotarget.22223","article-title":"Dynamic changes in the cell membrane on three dimensional low coherent quantitative phase microscopy (3D LC-QPM) after treatment with the near infrared photoimmunotherapy","volume":"8","author":"Ogata","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.lungcan.2026.109427_b0060","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.18632\/oncotarget.14425","article-title":"Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity","volume":"8","author":"Ogawa","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109427_b0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2326-6066.CIR-18-0546","article-title":"Host Immunity following near-infrared photoimmunotherapy is enhanced with PD-1 checkpoint blockade to eradicate established antigenic tumors","volume":"7","author":"Nagaya","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.lungcan.2026.109427_b0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/intimm\/dxaa037","article-title":"Near-infrared photoimmunotherapy of cancer: a new approach that kills cancer cells and enhances anti-cancer host immunity","volume":"33","author":"Kobayashi","year":"2021","journal-title":"Int. Immunol."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109427_b0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrm1962","article-title":"EGF-ERBB signalling: towards the systems level","volume":"7","author":"Citri","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.lungcan.2026.109427_b0080","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3390\/cancers13112535","article-title":"Near Infrared Photoimmunotherapy; a Review of Targets for Cancer Therapy","volume":"13","author":"Kato","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109427_b0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lungcan.2005.10.016","article-title":"EGFR overexpression in malignant pleural mesothelioma. An immunohistochemical and molecular study with clinico-pathological correlations","volume":"51","author":"Destro","year":"2006","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.lungcan.2026.109427_b0090","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00432-008-0384-4","article-title":"Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma","volume":"134","author":"Okuda","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.lungcan.2026.109427_b0095","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1200\/JCO.2006.09.7634","article-title":"Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study","volume":"25","author":"Garland","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.lungcan.2026.109427_b0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ctrv.2010.11.004","article-title":"Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: where do we stand?","volume":"37","author":"Agarwal","year":"2011","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109427_b0105","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jso.21901","article-title":"Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations","volume":"104","author":"Rena","year":"2011","journal-title":"J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109427_b0110","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1158\/1078-0432.CCR-04-1940","article-title":"Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B","volume":"11","author":"Govindan","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.lungcan.2026.109427_b0115","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00262-021-03124-x","article-title":"Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy","volume":"71","author":"Okada","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"issue":"9","key":"10.1016\/j.lungcan.2026.109427_b0120","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.3390\/cancers12092575","article-title":"Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors","volume":"12","author":"Maruoka","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.lungcan.2026.109427_b0125","doi-asserted-by":"crossref","first-page":"698","DOI":"10.7150\/thno.11559","article-title":"Near infrared photoimmunotherapy in the treatment of pleural disseminated NSCLC: preclinical experience","volume":"5","author":"Sato","year":"2015","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109427_b0130","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/biomedicines10040846","article-title":"Endoscopic applications of near-infrared photoimmunotherapy (NIR-PIT) in cancers of the digestive and respiratory tracts","volume":"10","author":"Furumoto","year":"2022","journal-title":"Biomedicines"},{"issue":"14","key":"10.1016\/j.lungcan.2026.109427_b0135","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.3390\/cancers16142558","article-title":"Evaluation of a novel lateral emitting laser fiber for near-infrared photoimmunotherapy","volume":"16","author":"Suzuki","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lungcan.2026.109427_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103345","article-title":"Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials","volume":"67","author":"Okada","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lungcan.2026.109427_b0145","doi-asserted-by":"crossref","unstructured":"M.A. Hsu, S.M. Okamura, C.D. De Magalhaes Filho, D.M. Bergeron, A. Rodriguez, M. West, D. Yadav, R. Heim, J.J. Fong, M. Garcia-Guzman, Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model, Cancer Immunol. Immunother. 72(1) (2023) 151-168. https:\/\/doi.org\/10.1007\/s00262-022-03239-9.","DOI":"10.1007\/s00262-022-03239-9"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109427_b0150","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1159\/000540242","article-title":"Therapeutic host anticancer immune response through photoimmunotherapy for head and neck cancer may overcome resistance to immune checkpoint inhibitors","volume":"17","author":"Koyama","year":"2024","journal-title":"Case Rep. Oncol."},{"key":"10.1016\/j.lungcan.2026.109427_b0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lungcan.2020.12.028","article-title":"Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival","volume":"153","author":"Chia","year":"2021","journal-title":"Lung Cancer"},{"issue":"17","key":"10.1016\/j.lungcan.2026.109427_b0160","doi-asserted-by":"crossref","first-page":"23361","DOI":"10.18632\/oncotarget.8025","article-title":"Near infrared photoimmunotherapy with an anti-mesothelin antibody","volume":"7","author":"Nagaya","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.lungcan.2026.109427_b0165","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3390\/cells9041019","article-title":"Targeted phototherapy for malignant pleural mesothelioma: near-infrared photoimmunotherapy targeting podoplanin","volume":"9","author":"Nishinaga","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.lungcan.2026.109427_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103372","article-title":"Near-infrared photoimmunotherapy targeting GPR87: Development of a humanised anti-GPR87 mAb and therapeutic efficacy on a lung cancer mouse model","volume":"67","author":"Yasui","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.lungcan.2026.109427_b0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF00880061","article-title":"Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion","volume":"11","author":"Manzotti","year":"1993","journal-title":"Clin. Exp. Metastasis"},{"issue":"2","key":"10.1016\/j.lungcan.2026.109427_b0180","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jso.25150","article-title":"Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery","volume":"118","author":"Lwin","year":"2018","journal-title":"J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2026.109427_b0185","doi-asserted-by":"crossref","first-page":"991","DOI":"10.21037\/tlcr-21-828","article-title":"Malignant pleural mesothelioma nodules remodel their surroundings to vascularize and grow","volume":"11","author":"Kovacs","year":"2022","journal-title":"Transl Lung Cancer Res."},{"issue":"4","key":"10.1016\/j.lungcan.2026.109427_b0190","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/cancers14040981","article-title":"Fibrosis in Mesothelioma: potential Role of Lysyl Oxidases","volume":"14","author":"Perryman","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109427_b0195","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1021\/bc200648m","article-title":"Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate","volume":"23","author":"Mitsunaga","year":"2012","journal-title":"Bioconjug. Chem."},{"issue":"25","key":"10.1016\/j.lungcan.2026.109427_b0200","doi-asserted-by":"crossref","first-page":"12504","DOI":"10.1039\/C5NR05552K","article-title":"Super enhanced permeability and retention (SUPR) effects in tumors following near infrared photoimmunotherapy","volume":"8","author":"Kobayashi","year":"2016","journal-title":"Nanoscale"},{"issue":"8","key":"10.1016\/j.lungcan.2026.109427_b0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136829","article-title":"Near infrared photoimmunotherapy targeting EGFR positive triple negative breast cancer: optimizing the conjugate-light regimen","volume":"10","author":"Nagaya","year":"2015","journal-title":"PLoS One"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226004885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226004885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:27:11Z","timestamp":1783106831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226004885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"alternative-id":["S0169500226004885"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109427","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermal growth factor receptor-targeted near-infrared photoimmunotherapy for malignant pleural mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109427","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109427"}}